BioCentury | Aug 4, 2016
Distillery Therapeutics

Therapeutics: MicroRNA-3662 (miR-3662)

...human leukemia cells, miR-3662 increased apoptosis. In two xenograft mouse models of AML, overexpression of miR-3662...
...time to disease onset and survival, compared with normal miR-3662 expression. Next steps include testing miR-3662...
...in models of AML and other bone marrow-related diseases, including sickle cell disease (SCD). TARGET/MARKER/PATHWAY: MicroRNA-3662 (miR-3662)...
Items per page:
1 - 1 of 1